LCP1 and renal cell carcinoma: Subsequent determination of NNMT, L-plastin (LCP1), and nonmetastatic cells 1 protein (NM23A) levels, performed in a wide number of plasma samples obtained from healthy donors and RCC patients, was used to explore the clinical performance of a three-marker assay for the early diagnosis of kidney cancer.